Ambaw Bellete

Ambaw Bellete serves as chief operating officer at FerGene where he has responsibility for the overall commercial organization comprised of sales and marketing, communications and advocacy, analytics, health outcomes research, business development, and patient access.

With more than 30 years of experience working in the biotech industry, Ambaw has a strong track record of success building and managing multidisciplinary teams from pre-launch to commercialization. Prior to joining FerGene, Ambaw served as the president of Photocure, a company focused on developing and commercializing pharmaceutical products based on photodynamic technology to treat bladder cancer. He grew revenues by 133% over his last 24 months in the organization, which drove an increase in the share price of the company by over 89% in 2019.

Ambaw has also held several global leadership positions with biopharma, biotech and medical device companies, including president of Medical Compression Systems. He started his biopharma career at the Upjohn Company (now Pfizer) and then Sanofi, where he held diverse leadership roles in business development, managed care, marketing and sales positions in specialty, oncology and urology. Ambaw currently serves on the board of directors for BioNJ.